GlassScriptPhysician profile
Paul V Polishuk
NPI 1487648754
$2,228.89
in general payments reported to CMS, 2019-2025
26 companies · $612 in 2025
The $612 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $252 · 2020: $75.34 · 2021: $169 · 2022: $294 · 2023: $214 · 2024: $613 · 2025: $612.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,349 · Education: $90.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,349.00 |
| Education | $90.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $515.72 | 2019-2024 | Speedicath, Titan |
| Janssen Biotech, INC. | $344.81 | 2023-2025 | Erleada |
| Abbvie INC. | $335.18 | 2019-2025 | |
| Boston Scientific Corporation | $126.91 | 2024 | Rezum Generator |
| Accord Healthcare, INC. | $113.00 | 2024-2025 | |
| Astellas Pharma US INC | $100.93 | 2019-2023 | Myrbetriq |
| Pfizer INC. | $90.95 | 2024-2025 | |
| Acclarent, INC | $90.08 | 2019 | |
| Progenics Pharmaceuticals, INC. | $88.80 | 2024 | |
| Endo Pharmaceuticals INC. | $50.20 | 2019-2023 | Xiaflex |
| Laborie Medical Technologies Corp. | $45.47 | 2025 | |
| Olympus America INC. | $41.84 | 2023-2025 | Cysto-Nephro Videoscope, Itind System |
| Myriad Genetic Laboratories, INC. | $28.93 | 2025 | Prolaris |
| Astrazeneca Pharmaceuticals LP | $27.04 | 2025 | |
| Ferring Pharmaceuticals INC. | $26.24 | 2019-2025 | Adstiladrin |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $23.93 | 2019 | |
| Immunitybio, INC. | $23.24 | 2024 | |
| Hollister Incorporated | $22.91 | 2023 | Vapro |
| Urogen Pharma, INC. | $22.51 | 2025 | |
| Welch Allyn | $17.53 | 2021 | |
| 180 Medical, INC. | $17.38 | 2024 | Gentlecath Glide |
| Kci USA, INC. | $16.21 | 2022 | |
| Allergan, INC. | $15.54 | 2019 | |
| Palette Life Sciences, INC. | $15.23 | 2022 | |
| Abc Home Medical Supply, INC. | $14.67 | 2022 | |
| Urovant Sciences INC | $13.64 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Polishuk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.